Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Cash & Equivalents: 2023-2024

Historic Cash & Equivalents for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to $64.0 million.

  • Camp4 Therapeutics' Cash & Equivalents rose 2878.64% to $75.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.3 million, marking a year-over-year increase of 2878.64%. This contributed to the annual value of $64.0 million for FY2024, which is 66.86% up from last year.
  • Camp4 Therapeutics' Cash & Equivalents amounted to $64.0 million in FY2024, which was up 66.86% from $38.4 million recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Cash & Equivalents registered a high of $64.0 million during FY2024, and its lowest value of $38.4 million during FY2023.
  • In the last 2 years, Camp4 Therapeutics' Cash & Equivalents had a median value of $51.2 million in 2023 and averaged $51.2 million.
  • Data for Camp4 Therapeutics' Cash & Equivalents shows a peak YoY spiked of 66.86% (in 2024) over the last 5 years.
  • Over the past 2 years, Camp4 Therapeutics' Cash & Equivalents (Yearly) stood at $38.4 million in 2023, then skyrocketed by 66.86% to $64.0 million in 2024.